Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Well documented guideline study conducted under GLP-conditions.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996
Report date:
1996

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
3-Butene-1,2-diol, diacetate
IUPAC Name:
3-Butene-1,2-diol, diacetate
Constituent 2
Chemical structure
Reference substance name:
1,2-diacetoxybut-3-ene
EC Number:
421-720-5
EC Name:
1,2-diacetoxybut-3-ene
Cas Number:
18085-02-4
Molecular formula:
C8 H12 O4
IUPAC Name:
1,2-diacetoxybut-3-ene
Constituent 3
Reference substance name:
DIACETOXYBUTENE
IUPAC Name:
DIACETOXYBUTENE
Details on test material:
- Name of test material (as cited in study report): 3,4-DIACETOXY-1-BUTENE
- Physical state: Liquid, clear/colorless
- Other: Source: Eastman Kodak Chemical Company

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Crl:CD(SD)BR VAF plus; Charles River Kingston (Stone Ridge, NY)
- Age at study initiation: male rats were 6 weeks of age; female rats were 7 weeks of age
- Weight at study initiation: male rats weighed 129 to 157 grams; female rats weighed 135 to 162 grams
- Fasting period before study: overnight before single dose gavage
- Housing: rats were singly housed in suspended, stainless-steel, wire mesh cages. Cages and racks were washed once a week. Absorbent paper, used to collect excreta, was changed at least three times a week.
- Diet (e.g. ad libitum): Certified Rodent Diet (PMI® #5002, pelleted) was available ad libitum
- Water (e.g. ad libitum): Water was available ad libitum through an automatic watering system
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 54-61
- Air changes (per hr): no details
- Photoperiod (hrs dark / hrs light): photoperiod of 12 hours light from 6 a.m. to 6 p.m.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: The test subst ance, a liquid, was administered as received

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Based on results of a range-finding test, doses of 500, 1000, and 2000 mg/kg of the test substance were selected as the dose levels for the oral toxicity study .
Doses:
500, 1000 and 2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Body weights were collected on Days 0(prior to treatment), 7, and 14.
- Necropsy of survivors performed: yes
- Other examinations performed:
1. clinical signs: Animals were observed three times on the day of dosing (Day 0), and once each day thereafter for the duration of the experiment . Observations included, but were not limited to, examination of the hair, skin, eyes, mucous membranes, motor activity, feces, urine, respiratory system, circulatory system, autonomic nervous system, central nervous system, and behavior patterns.
2. other: necropsy: Any animal that died during the study was necropsied as soon as possible. All surviving animals were euthanatized and necropsied at the completion of the 14-day observation period .
Statistics:
No dose/mortality curve was constructed since graphs become statistically useful only with the use of large numbers of animals and dose groups . No furhter data given.

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
794 mg/kg bw
95% CL:
483 - 1 305
Remarks on result:
other: combined LD50
Sex:
male
Dose descriptor:
LD50
Effect level:
891 mg/kg bw
95% CL:
451 - 1 759
Sex:
female
Dose descriptor:
LD50
Effect level:
707 mg/kg bw
95% CL:
318 - 1 574
Mortality:
Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 5
Male: 1000 mg/kg bw; Number of animals: 5; Number of deaths: 2
Male: 500 mg/kg bw; Number of animals: 5; Number of deaths: 2
Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 5
Female: 1000 mg/kg bw; Number of animals: 5; Number of deaths: 3
Female: 500 mg/kg bw; Number of animals: 5; Number of deaths: 2
Clinical signs:
other: Signs of toxicity related to dose levels: Clinical signs observed during the 14-day observation period included slight to severe weakness, vasodilation, and reduced feces. Severe weakness was noted only in animals assigned to the 2000 mg/kg dose group,
Gross pathology:
Effects on organs: The cause of death for the rats which died after treatment with the test substance was not determined. The treatment-
related changes observed at necropsy for the 2000 mg/kg animals and for the 1000 mg/kg female rats, which died within 24 hours of dosing, consisted of minimal to moderate hemorrhage in the glandular gastric mucosa. No treatment- related changes were observed at necropsy for the remaining
1000 mg/kg animals for any 500 mg/kg animals.

Any other information on results incl. tables

The test substance was a gastric tract irritant as evidenced by hemorrhage in the glandular gastric mucosa of rats from the 1000 and 2000 mg/kg bw dose groups. The acute oral LD50 for this test substance was calculated to be 891 mg/kg bw for male rats and 707 for female rats. Based on the oral LD50 calculated by combining the male and female mortality data (794 mg/kg bw), the test substance was classified as slightly toxic in rats according to the criteria set forth by Hodge and Sterner (1949) and harmful if swallowed as defined in the 18th Adaptation on the EC Classification, Packaging, and Labeling of Dangerous Substances.

Table 1: Results from the acute oral study (body weights)

 

Dose mg/kg bw

Day 0

Day 7

Day 14

Male rats

500

136

Died Day 1

/

500

137

222

284

500

138

Died Day 1

/

500

151

246

316

500

157

255

320

1000

145

Died Day 1

/

1000

129

Died Day 1

/

1000

146

236

306

1000

155

240

317

1000

146

207

297

2000

151

Died Day 1

/

2000

143

Died Day 1

/

2000

154

Died Day 1

/

2000

142

Died Day 1

/

2000

143

Died Day 1

/

Female rats

500

148

213

245

500

138

189

217

500

135

203

231

500

145

Died Day 1

/

500

147

Died Day 1

/

1000

148

Died Day 1

/

1000

157

Died Day 1

/

1000

161

205

245

1000

162

Died Day 1

/

1000

154

214

247

2000

146

Died Day 1

/

2000

142

Died Day 1

/

2000

147

Died Day 1

/

2000

144

Died Day 1

/

2000

144

Died Day 1

/

Applicant's summary and conclusion